Bioproperty, Biomedicine and Deliberative Governance: Patents as Discourse on Life
Autor Katerina Siderien Limba Engleză Paperback – 7 iun 2017
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 297.82 lei 6-8 săpt. | |
Taylor & Francis – 7 iun 2017 | 297.82 lei 6-8 săpt. | |
Hardback (1) | 816.41 lei 6-8 săpt. | |
Taylor & Francis – 17 dec 2014 | 816.41 lei 6-8 săpt. |
Preț: 297.82 lei
Preț vechi: 341.55 lei
-13% Nou
Puncte Express: 447
Preț estimativ în valută:
57.00€ • 59.41$ • 47.45£
57.00€ • 59.41$ • 47.45£
Carte tipărită la comandă
Livrare economică 04-18 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781138642805
ISBN-10: 1138642800
Pagini: 208
Dimensiuni: 156 x 234 x 11 mm
Greutate: 0.45 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge
Locul publicării:Oxford, United Kingdom
ISBN-10: 1138642800
Pagini: 208
Dimensiuni: 156 x 234 x 11 mm
Greutate: 0.45 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge
Locul publicării:Oxford, United Kingdom
Notă biografică
Dr Katerina Sideri is currently lecturing at The Open University, Greece. During the writing of the book she was Associate Research Fellow at the Centre for Socio-Legal Studies, University of Oxford. Her research interests are in the areas of: Deliberative Governance; Bioethics; Intellectual Property Law and Policy, Biomedical and Biotechnology Patents, Behaviour and Functions of Administrative Agencies. She has published widely on these and related areas.
Recenzii
'Patenting in the life sciences is a controversial area of law and policy with implications for health and human society more generally. This highly original, erudite and insightful book identifies the issues that should really concern us, and suggests ways to resolve them that policymakers and scholars across a range of social science disciplines would do well to heed.' Graham Dutfield, University of Leeds, UK ’In this book, Katerina Sideri engages with a cluster of some of the most pressing social and ethical issues of our time concerning the appropriate role and limits of technological innovation. Sideri argues, rightly in my view, that more attention needs to be paid to the potential role of institutions, such as patents, in reinforcing key ethical understandings about human behaviour, wellbeing, and the value of knowledge. This is an important book that will be of great interest to anyone concerned with questions about the appropriate future role of biotechnology and of scientific innovation more broadly.’ Michael Parker, University of Oxford, UK
Cuprins
Chapter 1 Introduction Patents as Discourse on Life: The Purposes of Patents in the Field of Biotechnology and Biomedical Innovation; Part I The European Patent Office and the Question of Legitimacy: Morality, Ethics and Technocracy; Chapter 2 The European Patent Office, Biotechnology and Ethics: Revising Ends of Policy and Rethinking Public Deliberation; Chapter 3 Neutral or Practically Wise Regulator? Genes, Patents and Human Health; Chapter 4 Rethinking Multilevel Governance in the EU and the Future of the EPO: From Morality to Ethics; Part II Patents and Public Bioethics; Chapter 5 Public Bioethics: Lay Opinions, and Human Need: From Sex Selection to Enhancement; Chapter 6 EPO and Public Bioethics: Germ Line Interventions in Human Embryos, the Problem of Commodification and the Question of Incentives; Part III Patents, Global Trade and Bioethics: Rethinking Good Governance; Chapter 7 TRIPs, Access to Medicines and the Global Governance of Patents: Cultivating Humanity and Equity; Chapter 8 Global Health Networks and Discursive Legitimacy; Chapter 9 Some Reflections on Good Patent Governance; Chapter 10 Conclusions: A Discursive Analysis of Patents;
Descriere
Biomedical patents have been the subject of heated debate and this book looks in detail into the legal issues and ethical debates raised. The volume seeks to contribute to our understanding of the role and function of regulatory agencies in the regulation of the bioeconomy, explains the process of interpretation of legal norms and proposes ways to rethink the reform of the patent system through the lens of legitimacy.